Investing IdeasBrowse All StocksMarkets
Have your own idea? Try our Stock Screener
Header cover image

Danish (OMX) Pharma Industry Analysis

UpdatedAug 23, 2026
DataAggregated Company Financials
Companies5
  • 7D1.8%
  • 3M3.0%
  • 1Y-16.3%
  • YTD-8.6%

Over the last 7 days, the Pharma industry has risen 1.8%, driven by gains from Novo Nordisk of 2.1%. In contrast, the industry has lost 16% in the last 12 months. As for the next few years, earnings are expected to grow by 1.8% per annum.

Industry Valuation and Performance

Has the Danish Pharma Industry valuation changed over the past few years?

DateMarket CapRevenueEarningsPEAbsolute PEPS
Sun, 23 Aug 2026DKK 1.4tDKK 362.2bDKK 121.7b11.4x11.7x3.9x
Tue, 21 Jul 2026DKK 1.5tDKK 359.9bDKK 126.9b11.9x12.2x4.3x
Thu, 18 Jun 2026DKK 1.4tDKK 359.9bDKK 126.9b11.2x10.7x3.8x
Sat, 16 May 2026DKK 1.4tDKK 359.9bDKK 126.9b11x11.2x4x
Mon, 13 Apr 2026DKK 1.2tDKK 340.0bDKK 106.8b12.5x10.8x3.4x
Wed, 11 Mar 2026DKK 1.2tDKK 340.0bDKK 106.8b11.9x11.1x3.5x
Fri, 06 Feb 2026DKK 1.3tDKK 339.8bDKK 106.7b12.2x12.5x3.9x
Sun, 04 Jan 2026DKK 1.6tDKK 345.8bDKK 108.6b14.1x14.4x4.5x
Tue, 02 Dec 2025DKK 1.5tDKK 345.8bDKK 108.6b13.5x13.7x4.3x
Thu, 30 Oct 2025DKK 1.6tDKK 341.3bDKK 115.5b13.5x13.7x4.6x
Sat, 27 Sep 2025DKK 1.6tDKK 341.3bDKK 115.5b13.9x14.2x4.8x
Mon, 25 Aug 2025DKK 1.7tDKK 341.3bDKK 115.5b14.6x14.7x5x
Wed, 23 Jul 2025DKK 2.0tDKK 331.8bDKK 108.8b18x18x5.9x
Fri, 20 Jun 2025DKK 2.2tDKK 331.8bDKK 108.8b20.7x20.6x6.8x
Sun, 18 May 2025DKK 2.0tDKK 331.8bDKK 108.8b18.1x18.1x5.9x
Tue, 15 Apr 2025DKK 2.0tDKK 317.9bDKK 104.9b19.2x19x6.3x
Thu, 13 Mar 2025DKK 2.3tDKK 317.9bDKK 104.9b22.3x22.1x7.3x
Sat, 08 Feb 2025DKK 2.9tDKK 317.8bDKK 104.9b27.6x27.3x9x
Mon, 06 Jan 2025DKK 2.9tDKK 297.4bDKK 98.2b29.9x29.6x9.8x
Wed, 04 Dec 2024DKK 3.5tDKK 297.4bDKK 98.2b36.5x36x11.9x
Fri, 01 Nov 2024DKK 3.5tDKK 283.9bDKK 93.2b38x37.5x12.3x
Sun, 29 Sep 2024DKK 3.6tDKK 283.9bDKK 93.2b39.3x38.8x12.7x
Tue, 27 Aug 2024DKK 4.1tDKK 283.9bDKK 93.2b44.5x43.9x14.4x
Thu, 25 Jul 2024DKK 4.1tDKK 269.3bDKK 92.2b44.8x44.2x15.1x
Sat, 22 Jun 2024DKK 4.5tDKK 269.3bDKK 92.2b49.1x48.3x16.5x
Mon, 20 May 2024DKK 4.1tDKK 269.3bDKK 92.2b44.9x44.2x15.1x
Wed, 17 Apr 2024DKK 4.0tDKK 257.0bDKK 86.4b46.3x46.1x15.5x
Fri, 15 Mar 2024DKK 4.2tDKK 257.0bDKK 86.4b49.3x48.4x16.3x
Sun, 11 Feb 2024DKK 3.8tDKK 257.0bDKK 86.4b44.3x43.6x14.7x
Tue, 09 Jan 2024DKK 3.3tDKK 238.8bDKK 78.2b42.6x41.8x13.7x
Thu, 07 Dec 2023DKK 3.1tDKK 238.8bDKK 78.2b40.2x39.4x12.9x
Sat, 04 Nov 2023DKK 3.1tDKK 238.6bDKK 78.1b40.6x39.8x13x
Mon, 02 Oct 2023DKK 2.9tDKK 225.4bDKK 70.1b42.8x41.9x13x
Wed, 30 Aug 2023DKK 3.0tDKK 225.4bDKK 70.1b43.1x42.1x13.1x
Price to Earnings Ratio

42.1x


Total Market Cap: DKK 3.0tTotal Earnings: DKK 70.1bTotal Revenue: DKK 225.4bTotal Market Cap vs Earnings and Revenue0%0%0%
Danish Pharma Industry Price to Earnings3Y Average 28x202420252026
Current Industry PE
  • Investors are pessimistic on the Danish Pharmaceuticals industry, indicating that they anticipate long term growth rates will be lower than they have historically.
  • The industry is trading at a PE ratio of 11.7x which is lower than its 3-year average PE of 28.0x.
  • The 3-year average PS ratio of 9.2x is higher than the industry's current PS ratio of 3.9x.
Past Earnings Growth
  • The earnings for companies in the Pharmaceuticals industry have grown 20% per year over the last three years.
  • Revenues for these companies have grown 17% per year.
  • This means that more sales are being generated by these companies overall, and subsequently their profits are increasing too.

Industry Trends

Which industries have driven the changes within the Danish Healthcare industry?

DK Market0.75%
Healthcare2.02%
Pharma1.81%
Pharma1.81%
Industry PEThere are no additional sub-industries under this industry.
Forecasted GrowthThere are no additional sub-industries under this industry.

Top Stock Gainers and Losers

Which companies have driven the market over the last 7 days?

CompanyLast Price7D1YValuation
NOVO B Novo NordiskDKK 300.852.1%
+DKK 27.2b		-17.3%PE11.4x
STENO StenocareDKK 0.996.5%
+DKK 2.6m		14.1%PS3.7x
PEG Pharma Equity GroupDKK 0.0832.2%
+DKK 2.2m		-41.9%PB4x

Latest News

ALK B
DKK 216.00
ALK-Abelló
7D
-1.2%
1Y
3.3%
HLUN B
DKK 41.04
H. Lundbeck
7D
-3.5%
1Y
2.9%
Analysis Article • Aug 22

H. Lundbeck A/S (CPH:HLUN B) Second-Quarter Results Just Came Out: Here's What Analysts Are Forecasting For This Year

A week ago, H. Lundbeck A/S ( CPH:HLUN B ) came out with a strong set of second-quarter numbers that could potentially...
STENO
DKK 0.99
Stenocare
7D
6.5%
1Y
14.1%
NOVO B
DKK 300.85
Novo Nordisk
7D
2.1%
1Y
-17.3%
Narrative Update • Aug 21

NOVO B: Future Returns Will Rely On Obesity Pills Versus Pipeline Setbacks

Analysts have trimmed their price target for Novo Nordisk to DKK 309.73 from DKK 316.91. This reflects updated assumptions that incorporate a slightly higher discount rate, a revised revenue growth outlook, modestly stronger profit margins, and a lower future P/E multiple.
PEG
DKK 0.083
Pharma Equity Group
7D
2.2%
1Y
-41.9%